tirzepatide a1c reduction Comparison of hemoglobin among semaglutide, tirzepatide, and retatrutide. Comparable A1c reduction of retatrutide and in this indirect comparison. This disproves the hypothesis that adding glucagon agonism would increase glucose Mounjaro and Type 2 Diabetes:

Retnakaran and colleagues say their data indicate that combining a GLP-1 agonist with basal insulin can achieve the ideal triumvirate of short-term outcomes in diabetes management: potent glucose-lowering capacity without increased hypoglycaemia or weight gain

These injections are designed as a short-to-medium-term metabolic intervention, not a long-term ongoing treatment

Smart thermometers that send alerts to your phone when temperatures go out of range provide an extra layer of protection, especially for catching safety-critical temperature excursions during power outages or appliance malfunctions

I point out that the confidence intervals for ALL outcomes cross 1 (null effect) which I interperet to mean the true effect could either be increased or decreased risk

Margalit O, Mamtani R, Kopetz S , Yang YX, Lawrence YR, Abu-Gazala S, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B

Nowadays, peptides are one such therapy among gymgoers